CALLIE ROGERS: Open Payments
NPI 1518689397 · HARTSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 71 payments from 18 companies in 2025. Trend: 2023 $814 · 2024 $833 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $187 |
| Novo Nordisk Inc | 9 | $153 |
| Otsuka America Pharmaceutical, Inc. | 7 | $151 |
| Abbott Laboratories | 7 | $116 |
| Amgen Inc. | 5 | $82 |
| PFIZER INC. | 4 | $72 |
| Lilly USA, LLC | 4 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 4 | $35 |
Products named: REXULTI, Ozempic, FREESTYLE LIBRE 3, UBRELVY, VRAYLAR, OTEZLA, MOUNJARO, TRINTELLIX.
Industry payments across SC — which companies pay providers there.
